Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 4 | Hyman JonathanChief Technology Officer |  BRZEBraze, Inc.Open-market sale · 10b5-1 plan | SELL | $915K 20.0K sh | Nov 2, 2026 |
| 4 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | $43K 546 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 4 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 312 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 4 | Hansen GwennChief Scientific Officer |  NRIXNurix Therapeutics, Inc.Option exercise · 10b5-1 plan | M | — 3,750 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 1 | Canning Susan M.SVP, CLO, Corporate Secretary |  HAYWHayward Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $40K 2,500 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 1 | Canning Susan M.SVP, CLO, Corporate Secretary | HAYWHayward Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $31K 2,000 sh | Nov 2, 2026 traded Oct 29, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 546 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | $57K 325 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | $48K 263 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | $101K 567 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | $137K 567 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | $100K 406 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | $141K 406 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | $65K 312 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Bertolini JeffreyChief Operating Officer |  CARLCARLSMED, INC.Option exercise · 10b5-1 plan | M | — 243 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Bertolini JeffreyChief Operating Officer | CARLCARLSMED, INC. Option exercise · 10b5-1 plan | M | $542 243 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | $45K 325 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Hansen GwennChief Scientific Officer | NRIXNurix Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 3,573 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Hansen GwennChief Scientific Officer | NRIXNurix Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 2,859 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 406 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 262 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Hansen GwennChief Scientific Officer | NRIXNurix Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 3,573 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 406 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Hansen GwennChief Scientific Officer | NRIXNurix Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 2,859 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 312 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 567 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | $59K 543 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Hansen GwennChief Scientific Officer | NRIXNurix Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 3,750 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | $91K 312 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 263 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | $94K 307 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | $70K 307 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | $44K 262 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 567 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 325 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Hansen GwennChief Scientific Officer | NRIXNurix Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $2,701 1,452 sh | Nov 2, 2026 traded Nov 2, 2026 |
| 0 | Hansen GwennChief Scientific Officer | NRIXNurix Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 1,452 sh | Nov 2, 2026 traded Nov 2, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 543 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Option exercise · 10b5-1 plan | M | — 325 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 56 | Charnley Nina ADirector |  BBTBeacon Financial CorpOpen-market purchase | BUY | $11K 350 sh | Oct 30, 2026 traded Oct 30, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 98 insiders$625K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369KBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K